Mechanism of Action
Fusion Protein Inhibitors
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
Clinical Trials (5)
Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.
Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis